Connecticut Lawmakers to Review Cannabis Testing and Delivery Updates on February 23

Connecticut Lawmakers to Review Cannabis Testing and Delivery Updates on February 23

Connecticut’s General Law Committee is set to hold a public hearing on February 23 to examine new legislation that would reshape several aspects of the state’s cannabis regulations. Senate Bill 231, introduced earlier this week as a committee measure, outlines changes to marijuana testing procedures, delivery rules, and hybrid retailer requirements.

Requirements For Cannabis Businesses in Connecticut

Under the proposal, cannabis businesses in Connecticut would be required to submit product samples to licensed laboratories that follow standards established by the Commissioner of Consumer Protection. If a batch fails testing, companies would have 30 days to retest or submit a remediation plan for approval. Should the batch continue to fail or the business fail to comply, the entire supply would need to be destroyed within a set timeframe.

The legislation also clarifies who is permitted to deliver cannabis to consumers. Only licensed delivery services and authorized employees would be allowed to handle deliveries, while dispensaries, hybrid retailers, and micro-cultivators would gain expanded authority to deliver under certain conditions.

Requirements For Retailers And Dispensaries

Another provision addresses pharmacist requirements for hybrid retailers and dispensaries. The bill stipulates that a licensed pharmacist must be physically present for at least eight consecutive hours each week. Outside of those hours, telehealth consultations and remote dispensing would be permitted, provided they comply with Department of Consumer Protection policies.

Beyond cannabis, the measure also updates dealer registration rules for electronic nicotine delivery systems. These changes include stricter background check requirements and new grounds for denying or revoking registrations.

If the General Law Committee approves the bill following the February 23 hearing, it will advance to the full Senate for further consideration.

This story was orginally reported on The Marijuana Herald.

READ MORE CANNABIS NEWS
Archives
Categories
BEARD BROS PHARMS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.